⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9724295 | 0.80 | FDPS (0.39) | — | |
| SCHEMBL8568659 | 0.80 | KDM4E (0.33) | — | |
| SCHEMBL10563126 | 0.77 | CA4 (0.48) | — | |
| SCHEMBL285627 | 0.77 | CA4 (0.48) | — | |
| SCHEMBL28118806 | 0.76 | CA1 (0.46) | — | |
| SCHEMBL368535 | 0.74 | — | — | |
| SCHEMBL9619452 | 0.74 | CA4 (0.46) | — | |
| SCHEMBL1643232 | 0.74 | CA4 (0.46) | — | |
| SCHEMBL27473070 | 0.74 | CA4 (0.46) | — | |
| SCHEMBL10625772 | 0.72 | BLM (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1342156-A | Inhibition and treatment of hepatitis B virus and flavivirus by helioxanthin and its analogs | UNIV YALE (US) | 2002-03-27 | — | — | CN | disclosed |
| US-5834183-A | FOR DIAGNOSIS OF AUTOSOMAL DOMINANT SPINOCEREBELLAR ATAXIA TYPE 1 GENE | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1998-11-10 | — | — | US | disclosed |
| EP-0707647-A1 | GENE SEQUENCE FOR SPINOCEREBELLAR ATAXIA TYPE 1 AND METHOD FOR DIAGNOSIS | THE REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1996-04-24 | — | — | EP | disclosed |
| WO-1995001437-A2 | GENE SEQUENCE FOR SPINOCEREBELLAR ATAXIA TYPE 1 AND METHOD FOR DIAGNOSIS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1995-01-12 | — | — | WO | disclosed |